Caroline Baumal insider trades
Open-market stock purchases and sales by Caroline Baumal, Chief Medical Officer at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 3, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.5M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.5M |
| Apr 29, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| Jan 22, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $60.9K |
| Jan 20, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $37.3K |
| Jan 5, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $77.1K |
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 6 sales, last May 14, 2026